Thinking · Evidence

Rs 29,454 a trip: India's distance tax on healthcare now has an official number.

Abhijith Magal · 25 September 2026 · 9 min read

The rural medical travel cost in India has an official government number for the first time in a decade: Rs 29,454 per overnight trip, per the National Statistics Office's 80th-round Domestic Tourism Expenditure Survey, released on 23 September and covering July 2025 to June 2026. Urban households spend more per trip, Rs 41,649, but travel far less often for health. Across purposes, health and medical trips are the costliest category the survey measures, ahead of leisure, shopping and pilgrimage.

I spent nine years inside pharma access work, and the number that stopped me was not the rupee figure. It was the share. Health and medical reasons account for 38.4 per cent of all overnight trips made by rural households. In urban India the figure is 16.5 per cent. Nearly two in five times a rural household packs a bag and leaves home overnight, the destination is a hospital.

The composition of the spend tells you what the trip is. Rural families put about 75 per cent of it into treatment and medicines, and reimbursement from government schemes covers 8.2 per cent of the cost. Business Standard's read of the same survey found Uttar Pradesh, West Bengal and Bihar together account for more than 30 per cent of the country's health and medical overnight trips. Transport is buses for 32 per cent of rural overnight trips and hired vehicles for another 30.4 per cent; only 16.7 per cent of rural overnight trips end in a hotel or guest house. People sleep with relatives, in makeshift rooms, in hospital corridors.

What the survey cannot see

A tourism expenditure survey records trips that happened. It has no column for the trip that did not. The patient who skipped the follow-up because the fare competed with school fees, the elderly parent who waits out the monsoon because the hired vehicle will not cross a flooded causeway, the daily-wage worker who cannot lose three days of pay in a heatwave month: none of them appears, and each one is the version of this data that matters most for health outcomes.

So read Rs 29,454 as a floor, in two senses. It is the cost paid by households that managed to travel. And it is the baseline on which every climate disruption now compounds. A cut road does not create the distance tax; it raises it, in fare, in days, in the decision not to go at all. That compounding is climate-access in its most literal form: reachability breaking while the facility itself reports normal operations.

The slide this number belongs on

Health programme design in India usually opens with disease burden. This survey argues for opening with trip burden. A chronic patient on monthly reviews in a district where the nearest adequate facility is an overnight trip is carrying a recurring cost the NSO has now priced, and that cost is the first thing a climate event raises. A continuity programme that cuts trips, through decentralised refills at the PHC or sub-centre, review intervals matched to stability, or transport support timed to the season, is attacking a measured number rather than an asserted one.

The measurement design writes itself. In a programme district, record the trip burden of the enrolled cohort at baseline: trips per year, cost per trip, mode, and days lost. Then count the same through the programme. Trips avoided, multiplied by the household's own cost, is a benefit figure a CSR committee and a board can read without translation, and it comes from the household's ledger rather than a satisfaction survey. That baseline-then-count design is the core of the Continuity Cohort Method; a published version sits on Zenodo at doi.org/10.5281/zenodo.22861246. Where to point such a programme is a separate question; the district index covers how I rank exposure, and your own access data usually already holds the seasonal signal.

For pharma specifically, the connection is direct. The 75 per cent of trip spend that goes to treatment and medicines is the household's own money meeting the product partway. Every programme that moves a refill closer to the patient converts a priced, recurring household cost into adherence. I have sat in enough access reviews to know that argument lands differently from a goodwill argument.

One limit. The survey measures tourist households, defined as those reporting at least one overnight trip, so per-household rates read against that base rather than all households. The purpose shares and expenditure averages are national; district figures do not exist in this release. A programme should price its own district's trip burden from its baseline survey, and use the NSO figure as the national anchor it now is.

Common questions

How much does a medical trip cost a rural household in India?

Rs 29,454 per overnight health trip on average, per the NSO's Domestic Tourism Expenditure Survey covering July 2025 to June 2026. Urban households average Rs 41,649. Health trips are the costliest category of overnight domestic travel the survey measures.

How often do rural households travel for healthcare?

Rural tourist households make 49 overnight health trips per 100 households a year, more than double the urban rate of 22. Health accounts for 38.4 per cent of all rural overnight trips, against 16.5 per cent in urban areas.

Why does medical travel cost matter for climate and health?

The cost is a recurring burden that climate events raise directly: floods cut roads, heat makes travel dangerous for elderly and chronically ill patients, and disruptions add fare, days and risk to a trip that is already the costliest purpose of travel. The survey also counts only completed trips, so forgone care is invisible in the data.

How can a CSR or access programme use this figure?

As the baseline. Record the enrolled cohort's trips per year, cost per trip and days lost at the start, then count trips avoided through decentralised refills, adjusted review intervals or seasonal transport support. Trips avoided multiplied by the household's own cost is a benefit figure grounded in official national data.

Abhijith Magal

Founder, Syntropy Earth. Nine years across two global pharmaceutical multinationals in patient access and commercial roles, with health-equity work alongside the WHO-Foundation and UNICEF. He works on climate-access: where climate disruption breaks the link between patients and care.

Last updated: 3 October 2026